Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.

"Financial disclosures: Joseph M. Norris certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g. employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Norris receives funding from the Medical Research Council (MRC) and has previously received financial support for research from the National Institute of Health Research (NIHR), the Urology Foundation (TUF), and the Freemasons United Grand Lodge of England via the Royal College of Surgeons of England (RCSEng). Simpson receives funding from the Rosetrees Trust. Kirkham and Freeman have shares in Nuada Medical Ltd. Whitaker receives funding from Prostate Cancer UK, the Urology Foundation, and the Rosetrees Trust. Emberton receives funding from NIHR-i4i, MRC, Sonacare Inc., Trod Medical, Cancer Vaccine Institute, and Sophiris Biocorp for trials in prostate cancer; is a medical consultant to Sonacare Inc., Sophiris Biocorp, Steba Biotech, GSK, Exact Imaging, and Profound Medical; has stock interest in Nuada Medical Ltd; received travel allowance previously from Sanofi Aventis, Astellas, GSK, and Sonacare; and is a proctor for HIFU with Sonacare Inc. and is paid for training other surgeons in this procedure. The other authors declare no competing interests.

 Financial disclosures:"

"Funding/Support and role of the sponsor: Joseph M. Norris is funded by the 10.13039/501100000265MRC (Grant Reference: MR/S00680X/1). Benjamin S. Simpson is funded by the 10.13039/501100000833Rosetrees Trust."